The Response of RIF-1 Fibrosarcomas to the Vascular-Disrupting Agent ZD6126 Assessed by In Vivo and Ex Vivo1H Magnetic Resonance Spectroscopy
The response of radiation-induced fibrosarcoma1 (RIF-1) tumors treated with the vascular-disrupting agent (VDA) ZD6126 was assessed by in vivo and ex vivo1H magnetic resonance spectroscopy (MRS) methods. Tumors treated with 200 mg/kg ZD6126 showed a significant reduction in total choline (tCho) in v...
Main Authors: | Basetti Madhu, John C. Waterton, John R. Griffiths, Anderson J. Ryan, Simon P. Robinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-07-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558606800114 |
Similar Items
-
Single Dose of the Antivascular Agent, ZD6126 (N-Acetylcoichinol-O-Phosphate), Reduces Perfusion for at Least 96 Hours in the GH3 Prolactinoma Rat Tumor Model
by: Dominick J.O. McIntyre, et al.
Published: (2004-03-01) -
Acute Tumor Response to ZD6126 Assessed by Intrinsic Susceptibility Magnetic Resonance Imaging
by: Simon P. Robinson, et al.
Published: (2005-05-01) -
The accumulation of rare-earth yttrium ions by Penicillium sp. ZD28
by: Weiying Wang, et al.
Published: (2020-02-01) -
The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (Cryptotis parva)
by: W. Zhong, et al.
Published: (2021-04-01) -
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
by: Davis, P, et al.
Published: (2002)